pyridoxine has been researched along with Carotid Stenosis in 4 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
Carotid Stenosis: Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperhomocysteinemia has been identified as a potential risk factor for atherosclerosis." | 7.70 | Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS) ( Beilby, JP; Hung, J; McQuillan, BM; Nidorf, M; Thompson, PL, 1999) |
| "Hyperhomocysteinemia has been identified as a potential risk factor for atherosclerosis." | 3.70 | Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS) ( Beilby, JP; Hung, J; McQuillan, BM; Nidorf, M; Thompson, PL, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Selhub, J | 2 |
| Jacques, PF | 2 |
| Bostom, AG | 2 |
| D'Agostino, RB | 2 |
| Wilson, PW | 2 |
| Belanger, AJ | 2 |
| O'Leary, DH | 2 |
| Wolf, PA | 2 |
| Schaefer, EJ | 2 |
| Rosenberg, IH | 2 |
| Rush, D | 1 |
| Lentz, SR | 1 |
| Malinow, MR | 1 |
| Piegors, DJ | 1 |
| Bhopatkar-Teredesai, M | 1 |
| Faraci, FM | 1 |
| Heistad, DD | 1 |
| McQuillan, BM | 1 |
| Beilby, JP | 1 |
| Nidorf, M | 1 |
| Thompson, PL | 1 |
| Hung, J | 1 |
4 other studies available for pyridoxine and Carotid Stenosis
| Article | Year |
|---|---|
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Confidence Intervals; Cross-Sectional Studies; Female; Fo | 1995 |
Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Cohort Studies; Female; Folic Acid; Homocysteine; Humans; | 1996 |
Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
Topics: Acetylcholine; Adenosine Diphosphate; Animals; Arteriosclerosis; Carotid Arteries; Carotid Stenosis; | 1997 |
Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)
Topics: Adult; Aged; Amino Acid Substitution; Arteriosclerosis; Carotid Arteries; Carotid Stenosis; Comorbid | 1999 |